The ITM Rhenium-SCT™ is the new generation of non-invasive skin cancer therapy, provided by ITM OncoBeta GmbH - predominantly to patients with large and difficult to treat skin tumours .

The portfolio of ITG radioisotopes and generators utilized in the ITM Group has been carefully selected and developed to comply with a set of narrow and challenging specifications.

The ITM radioisotope production and supply systems are optimized to meet the quality and supply standards (interuption free, security of supply) required in a dynamically developing environment of a new generation of targeted, personalized therapies.